ZobairYounossiMDMPH

Hepatology & Liver Transplantation

Chairman, Beatty Liver and Obesity Research Program, Inova Health System Chairman, the Global NASH Council.

Dr. Younossi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3300 Gallows Rd
Medicine
Falls Church, VA 22042
Phone+1 703-776-2540

Fax+1 703-776-4388

PubMed

Focused Recommendations for the Management of Metabolic Dysfunction-Associated Steatohepatitis (MASH) by Advanced Practice Providers in the United States.
Brian P Lam, Jessica Bartholomew, Sherona Bau, HoChong Gilles, Andrea Keller
Journal of Clinical Gastroenterology. 2025-02-03
Fast score is associated with patient-reported outcomes in patients with metabolic dysfunction-associated steatotic liver disease.
Ryuki Hashida, Takumi Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Machiko Kawaguchi
European Journal of Gastroenterology & Hepatology. 2025-02-01
3 citations
Association of food insecurity with MASLD prevalence and liver-related mortality.
Zobair M Younossi, Shira Zelber-Sagi, Carina Kuglemas, Jeffrey V Lazarus, Annette Paik
Journal of Hepatology. 2025-02-01

Journal Articles

Disease Burden of Hepatocellular Carcinoma: A Global Perspective
Zobair M Younossi, Mehmet Sayiner, Digestive Diseases and Sciences
Diagnosis and Management of Primary Biliary Cholangitis
Zobair M Younossi, Kris V Kowdley, Ira M Jacobson, Mitchell L Shiffman, Paul Kwo, Nature
Health-Related Quality of Life in Patients with Autoimmune Hepatitis: A Questionnaire Survey
Zobair Younossi, MD, PLoS One
An Exploratory Study Examining How Nano-Liquid Chromatography–Mass Spectrometry and Phosphoproteomics Can Differentiate Patients with Advanced Fibrosis and Higher Perc...
Zobair M Younossi, Zachary D Goodman, BioMed Central
Impact of Non‐Malignant Portal Vein Thrombosis in Transplant Recipients with Nonalcoholic Steatohepatitis
Sanjaya K Satapathy, Ashwani Singal, Kalyan Ram Bhamidimarri, Zobair M Younossi, Liver transplantation
Disparities in Access to Direct Acting Antiviral Regimens for Hepatitis C Virus (HCV): The Impact of Race and Insurance Status
Zobair Younossi, MD, Nature
Changing Trends in Etiology‐ and Ethnicity‐Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States
Zobair M Younossi, Donghee Kim, Chiranjeevi Gadiparthi, Brandon J Perumpail, Hepatology
Join now to see all

Lectures

Current Management of NAFLD/NASH: Medical, Endoscopic, and Surgical Therapies
AGC 2018 Annual Scientific Meeting, Philadelphia, PA - 10/8/2018

Low-Income Adolescents Are at Higher Risk for Fatty Liver DiseaseOctober 14th, 2024
Costly Comorbidities Persist for the 90% of Patients with MASH and No CirrhosisSeptember 11th, 2024
New Update Focuses on Acute Kidney Injury Management in CirrhosisOctober 20th, 2022
Join now to see all